Villanova Investment Management Co LLC Has $500,000 Position in InMode Ltd. $INMD

Key Points

• Villanova Investment Management Co LLC has significantly reduced its stake in InMode Ltd. by 69.4%, holding only 28,162 shares valued at approximately $500,000 after selling 63,794 shares.
• During the first quarter, other institutional investors also adjusted their stakes, with Handelsbanken Fonder AB increasing its holdings by 34.3% and GAMMA Investing LLC raising its stake by an astounding 13,923.8%.
• InMode reported earnings per share of $0.47, which fell short of the expected $0.50, with quarterly revenue also missing estimates at $95.60 million against an expectation of $98.45 million.

Villanova Investment Management Co LLC decreased its holdings in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 69.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 28,162 shares of the healthcare company's stock after selling 63,794 shares during the period. Villanova Investment Management Co LLC's holdings in InMode were worth $500,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Price T Rowe Associates Inc. MD lifted its position in shares of InMode by 8.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 28,310 shares of the healthcare company's stock valued at $473,000 after acquiring an additional 2,256 shares during the last quarter. Northern Trust Corp increased its holdings in shares of InMode by 17.0% in the 4th quarter. Northern Trust Corp now owns 658,154 shares of the healthcare company's stock valued at $10,991,000 after purchasing an additional 95,652 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of InMode by 1.9% in the 4th quarter. Ameriprise Financial Inc. now owns 233,621 shares of the healthcare company's stock valued at $3,901,000 after purchasing an additional 4,308 shares during the period. BNP Paribas Financial Markets acquired a new position in shares of InMode in the 4th quarter valued at about $954,000. Finally, Deutsche Bank AG increased its holdings in InMode by 52.0% in the fourth quarter. Deutsche Bank AG now owns 66,700 shares of the healthcare company's stock worth $1,114,000 after buying an additional 22,820 shares during the last quarter. 68.04% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

INMD has been the topic of a number of research reports. Needham & Company LLC restated a "hold" rating on shares of InMode in a report on Wednesday, July 30th. Canaccord Genuity Group reaffirmed a "hold" rating and issued a $15.00 target price on shares of InMode in a research report on Friday, July 11th. Finally, Barclays reduced their target price on InMode from $24.00 to $21.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. One research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $18.04.

InMode Stock Down 3.3%

InMode stock traded down $0.51 during mid-day trading on Friday, hitting $14.83. 727,280 shares of the company were exchanged, compared to its average volume of 941,794. The business has a fifty day moving average of $14.53 and a 200 day moving average of $15.25. InMode Ltd. has a 1-year low of $13.14 and a 1-year high of $19.85. The company has a market capitalization of $937.40 million, a PE ratio of 6.00 and a beta of 2.00.

InMode (NASDAQ:INMD - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The healthcare company reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.03). InMode had a return on equity of 18.38% and a net margin of 44.50%.The company had revenue of $95.60 million for the quarter, compared to analyst estimates of $98.45 million. During the same quarter in the prior year, the company earned $0.34 earnings per share. The business's revenue was up 10.6% compared to the same quarter last year. Research analysts expect that InMode Ltd. will post 1.75 earnings per share for the current year.

InMode Company Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.